(Q41537372)

2 October 2017

1 reference

title

NSAID-induced polyp regression in familial adenomatous polyposis patients (English)

1 reference

familial adenomatous polyposis

2 October 2017

1 reference

Giardiello FM

1

1 reference

2 October 2017

1 June 1996

1 reference

Gastroenterology Clinics of North America

2 October 2017

1 reference

2 October 2017

25

1 reference

2 October 2017

349-362

1 reference

2 October 2017

2

1 reference

Nonsteroidal antiinflammatory drugs--differences and similarities

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Sulindac treatment for familial polyposis coli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Identification of FAP locus genes from chromosome 5q21

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Reduction of acetoxymethyl-methylnitrosamine-induced large bowel cancer in rats by indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

APC mutations occur early during colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Effects of Long-term Sulindac Therapy on Colonic Polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Rectal cancer in FAP patient after sulindac.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Sulindac for polyposis of the colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

Sulindac for polyposis of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970251-X

7 January 2021

10.1016/S0889-8553(05)70251-X

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9229577